PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells

被引:34
作者
Davies, L. [1 ]
Spiller, D. [2 ]
White, M. R. H. [2 ]
Grierson, I. [1 ]
Paraoan, L. [1 ]
机构
[1] Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool L69 3GA, Merseyside, England
[2] Univ Liverpool, Ctr Cell Imaging, Inst Integrat Biol, Liverpool L69 3GA, Merseyside, England
来源
CELL DEATH & DISEASE | 2011年 / 2卷
基金
英国生物技术与生命科学研究理事会;
关键词
PERP; apoptosis; uveal melanoma; p53; fluorescent protein; DAMAGE-INDUCED PHOSPHORYLATION; DNA-DAMAGE; P53-DEPENDENT APOPTOSIS; PROTEIN KINASE-2; DEGRADATION; MDM2; ACTIVATION; MEDIATOR; PATHWAY; GENE;
D O I
10.1038/cddis.2011.19
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The activation and regulation of target genes by the tumour-suppressor p53 dictates the fate of a cell, with cell cycle arrest or apoptosis being two distinct outcomes. PERP (p53 apoptosis effector related to PMP-22), a p53 transcriptional target, is induced specifically during apoptosis but not cell cycle arrest. Downregulation of PERP is associated with the aggressive, monosomy 3-type of uveal melanoma (UM), the most common primary intraocular tumour in adults, and increased PERP expression has a pro-apoptotic effect in UM cells. Here, we identify a novel effect of PERP expression, as elevated PERP protein positively influences active levels of its own transcriptional regulator, p53. Using fluorescent fusion proteins of PERP, p53 and MDM2, we demonstrate in single living UM cells that PERP expression significantly enhances p53 activity and its nuclear localization, increases p53-dependent transcription (including that of MDM2) while allowing oscillatory nucleo-cytoplasmic shuttling of p53/MDM2 complexes. Phosphorylation of p53 serine residues that interfere with the interaction between p53 and its negative regulator MDM2 and enhance pro-apoptotic gene transcription also occurs subsequent to PERP expression. These results implicate a role for PERP in amplifying functional p53 levels that promote p53-dependent apoptosis, and reveal a potential target for exploitation in enhancing p53 activity. Cell Death and Disease (2011) 2, e136; doi: 10.1038/cddis.2011.19; published online 31 March 2011
引用
收藏
页码:e136 / e136
页数:11
相关论文
共 41 条
  • [11] Mdm2 promotes the rapid degradation of p53
    Haupt, Y
    Maya, R
    Kazaz, A
    Oren, M
    [J]. NATURE, 1997, 387 (6630) : 296 - 299
  • [12] Hildebrandt T, 2000, ANTICANCER RES, V20, P2801
  • [13] Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2
    Hofmann, TG
    Möller, A
    Sirma, H
    Zentgraf, H
    Taya, Y
    Dröge, W
    Will, H
    Schmitz, ML
    [J]. NATURE CELL BIOLOGY, 2002, 4 (01) : 1 - 10
  • [14] Perp is a mediator of p53-dependent apoptosis in diverse cell types
    Ihrie, RA
    Reczek, E
    Horner, JS
    Khachatrian, L
    Sage, J
    Jacks, T
    Attardi, LD
    [J]. CURRENT BIOLOGY, 2003, 13 (22) : 1985 - 1990
  • [15] p53 gene and cell cycling in uveal melanoma
    Kishore, K
    Ghazvini, S
    Char, DH
    Kroll, S
    Selle, J
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 121 (05) : 561 - 567
  • [16] A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy
    Komarov, PG
    Komarova, EA
    Kondratov, RV
    Christov-Tselkov, K
    Coon, JS
    Chernov, MV
    Gudkov, AV
    [J]. SCIENCE, 1999, 285 (5434) : 1733 - 1737
  • [17] Regulation of p53 stability by Mdm2
    Kubbutat, MHG
    Jones, SN
    Vousden, KH
    [J]. NATURE, 1997, 387 (6630) : 299 - 303
  • [18] Dynamics of the p53-Mdm2 feedback loop in individual cells
    Lahav, G
    Rosenfeld, N
    Sigal, A
    Geva-Zatorsky, N
    Levine, AJ
    Elowitz, MB
    Alon, U
    [J]. NATURE GENETICS, 2004, 36 (02) : 147 - 150
  • [19] The P53 pathway: what questions remain to be explored?
    Levine, A. J.
    Hu, W.
    Feng, Z.
    [J]. CELL DEATH AND DIFFERENTIATION, 2006, 13 (06) : 1027 - 1036
  • [20] p53, the cellular gatekeeper for growth and division
    Levine, AJ
    [J]. CELL, 1997, 88 (03) : 323 - 331